Cargando…

Effects of Mitochondrial Translocation of Telomerase on Drug Resistance in Hepatocellular Carcinoma Cells

Hepatocellular carcinoma (HCC) cells exhibit multidrug resistance (MDR), but the underlying mechanisms remain unclear. Cancer cells that overexpress telomerase are resistant to chemotherapeutic drugs. This study aimed to determine the effects of mitochondrial translocation of telomerase on MDR in HC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jing, Zhou, Yuan, Chen, DaiXing, Li, LiLi, Yang, Xin, You, Yang, Ling, Xianlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280398/ https://www.ncbi.nlm.nih.gov/pubmed/25561980 http://dx.doi.org/10.7150/jca.10419

Ejemplares similares

Role of Mitochondrial Translocation of Telomerase in Hepatocellular Carcinoma Cells with Multidrug Resistance
por: Ling, Xianlong, et al.
Publicado: (2012)

Modulation of Mitochondrial Permeability Transition Pore Affects Multidrug Resistance in Human Hepatocellular Carcinoma Cells
por: Ling, Xianlong, et al.
Publicado: (2010)

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000)

Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma
por: Huang, Wan, et al.
Publicado: (2017)

Telomerase and drug resistance in cancer
por: Lipinska, Natalia, et al.
Publicado: (2017)

Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma
por: Tarocchi, Mirko, et al.
Publicado: (2014)

Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma
por: WU, TING-TING, et al.
Publicado: (2015)

Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma
por: Donaires, Flávia S., et al.
Publicado: (2017)

Asiaticoside Antagonizes Proliferation and Chemotherapeutic Drug Resistance in Hepatocellular Carcinoma (HCC) Cells
por: Ma, Ying, et al.
Publicado: (2020)

Noncoding telomeric repeat‐containing RNA inhibits the progression of hepatocellular carcinoma by regulating telomerase‐mediated telomere length
por: Cao, Haiyan, et al.
Publicado: (2020)

Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma
por: Kotiyal, Srishti, et al.
Publicado: (2021)

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2021)

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
por: Yang, Xunjun, et al.
Publicado: (2016)

Telomerase activation in nasopharyngeal carcinomas.
por: Cheng, R. Y., et al.
Publicado: (1998)

Telomerase Deficiency Affects the Formation of Chromosomal Translocations by Homologous Recombination in Saccharomyces cerevisiae
por: Meyer, Damon H., et al.
Publicado: (2008)

The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
por: Wei, Ling, et al.
Publicado: (2019)

Mitochondrial DNA depletion, mitochondrial mutations and high TFAM expression in hepatocellular carcinoma
por: Qiao, Lihua, et al.
Publicado: (2017)

Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
por: Dai, Xiao-Yang, et al.
Publicado: (2016)

Surgical Significance of Telomerase Activity in Noncancerous Liver Tissue from Patients with Hepatocellular Carcinoma
por: Kanamaru, Taichi, et al.
Publicado: (1998)

A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma
por: Wang, Szu-Jen, et al.
Publicado: (2021)

Expression of Telomerase Catalytic Component, Telomerase Reverse Transcriptase, in Human Gastric Carcinomas
por: Yasui, Wataru, et al.
Publicado: (1998)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma: Mff promotes cisplatin resistance in HCC
por: Li, Xiaoliang, et al.
Publicado: (2022)

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Nault, Jean Charles, et al.
Publicado: (2013)

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
por: Donati, Benedetta, et al.
Publicado: (2017)

Significance of cytoplasmic expression of telomerase reverse transcriptase in patients with hepatocellular carcinoma undergoing liver resection
por: Nishi, Yusuke, et al.
Publicado: (2021)

Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
por: Mender, Ilgen, et al.
Publicado: (2023)

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020)

Analysis of Characteristics, Pathogens and Drug Resistance of Urinary Tract Infection Associated with Long-Term Indwelling Double-J Stent
por: Li, Yuehua, et al.
Publicado: (2023)

Mitochondrial Quality Control in Hepatocellular Carcinoma
por: Bian, Jinda, et al.
Publicado: (2021)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice
por: HE, LEI, et al.
Publicado: (2013)

Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis
por: Wang, Jing, et al.
Publicado: (2022)

Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma
por: Liu, Yuying, et al.
Publicado: (2018)

Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
por: Wu, Xuping, et al.
Publicado: (2017)

Diverse regulatory manners of human telomerase reverse transcriptase
por: Jie, Meng-Meng, et al.
Publicado: (2019)

Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
por: Li, Ling, et al.
Publicado: (2016)

Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)

Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells
por: Li, Bingxin, et al.
Publicado: (2021)

Structure and function of echinoderm telomerase RNA
por: Podlevsky, Joshua D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_api40ogp1hjq7voj667ce4dq90